好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Assessment of a Movement Disorders Video Curriculum for Neurology Clerkships
Research Methodology, 好色先生, and History
P2 - Poster Session 2 (5:30 PM-6:30 PM)
4-039
To assess the accessibility of, quality of, appropriateness for training level of, and knowledge gained from newly developed movement disorders didactic videos in a neurology clerkship.
The movement disorders subspecialty of neurology relies heavily on careful visual observation of the abnormal movements (phenomenology), but medical students have little exposure to movement disorders during training. A prior study revealed a gap in available videos of phenomenology as a learning tool for medical students.
We developed didactic videos of movement disorders with a standardized format. Students enrolled in the required neurology clerkship completed a 4-question pre-viewing assessment, viewed 5 videos, completed a 4-question post-viewing assessment and a 10-question user survey.
15 participants completed the assessment, with a mean pre-viewing score of 80% and improvement to 98% on the post-viewing assessment. 18 participants completed the survey, with 100% agreeing or strongly agreeing that the videos were easy to access, played correctly, had clearly written didactic information, were an appropriate length, were at an appropriate training level, and helped them better understand the neurological condition presented. 83% agreed or strongly agreed that they would continue to use the videos as a learning tool and 89% agreed or strongly agreed that they would recommend the videos to their peers.
The results show that the didactic videos are an effective educational tool at an appropriate level to teach about neurological conditions that students have little clinical exposure to, and that the students will continue to use the videos and recommend them to peers. This suggests that inclusion of the video curriculum into the neurology clerkship curriculum will enhance understanding of common neurological disorders.
Authors/Disclosures
Sagari R. Bette, MD (Parkinson's Disease and Movement Disorders Center of Boca Raton)
PRESENTER
Dr. Bette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Bette has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal. Dr. Bette has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyowa Kirin. Dr. Bette has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merz. Dr. Bette has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Bette has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Bette has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merz. Dr. Bette has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus.
Danielle S. Shpiner, MD An immediate family member of Dr. Shpiner has received personal compensation for serving as an employee of University of Miami. Dr. Shpiner has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Mission MSA. The institution of Dr. Shpiner has received research support from American Parkinson's Disease Association. The institution of Dr. Shpiner has received research support from CurePSP. The institution of Dr. Shpiner has received research support from Parkinson's Foundation. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Parkinson's Foundation that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Medtronic that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Boston Scientific that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbott that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbvie that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Ipsen that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Amneal that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Michael J. Fox Foundation that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a CoC Medical Director with CurePSP that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Mission MSA that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Merz that is relevant to AAN interests or activities.
Jason H. Margolesky, MD, FAAN (University of Miami School of Medicine) Dr. Margolesky has nothing to disclose.
Corneliu C. Luca, MD (University of Miami) Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Luca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Signant Health. Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott.
Henry P. Moore, MD (University of Miami - Miller School of Medicine) Dr. Moore has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Dr. Moore has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen Pharma. The institution of Dr. Moore has received research support from Sage Therapeutics. The institution of Dr. Moore has received research support from Bukwang Pharmaceutical. The institution of Dr. Moore has received research support from Neurocrine. The institution of Dr. Moore has received research support from CDHI Foundation. The institution of Dr. Moore has received research support from MODUS Outcomes LLC. The institution of Dr. Moore has received research support from University of Kansas Center for Research.
Carlos Singer, MD (University of Miami) Dr. Singer has nothing to disclose.
Yolanda Reyes-Iglesias, MD, FAAN (University of Miami) Dr. Reyes-Iglesias has received personal compensation in the range of $500-$4,999 for serving as a Member Neuroscience Test Development Material Committee with National Board medical examiners (NBME). Dr. Reyes-Iglesias has received personal compensation in the range of $500-$4,999 for serving as a Lecturer with Harvard Prime Med Series.